ENOV: Enovis Corporation Forward P/E Multiple

Graphic logo of enovis.com (ENOV)

Amid medtech consolidation and the battle for surgical contracts, the current forward P/E of Enovis Corporation (ENOV) on the GURU.Markets chart reflects the market's reaction to competition. Stable revenue from DJO implants and braces, combined with patent protection, ensures resilience, while 7.90 characterizes this valuation metric, determining the objectivity of the asset's value relative to expected earnings.

enovis.com - ENOV Price to Expected Earnings Ratio (period 04/28/2023 - 11/18/2026)

Enovis (ENOV) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Fundamental valuation:ENOV Enovis Inc.
Brand item of enovis.com

The forward P/E determines the current share price relative to the expected earnings per share for the next period. By analyzing the forward P/E chart for Enovis Corporation (ENOV), an investor assesses market expectations regarding business growth rates. Management stability at Enovis Corporation (ENOV) following the integration of acquired medtech assets directly impacts the accuracy of these forecasts. This ratio's price action reflects market confidence in the realization of operational synergies, allowing investors to balance the risk of overpayment against capitalization potential.

Competitors of Enovis Corporation

Forward P/E Multiple BSX|EW: Price to Expected Earnings Ratio|ResMed Corp - Projected Price to Earnings|Market Cap to Projected Earnings Insulet (PODD)|zimmerbiomet.com - Forward P/E Multiple|Projected Price to Earnings Ratio CooperCompanies|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec)|Projected Price to Earnings AORT (Artivion)|IART (Integra LifeSciences Corp) - Future Price to Earnings Multiple|Future Price to Earnings Establishment Labs Inc ESTA|BBNX - Projected Price to Earnings|IRADIMED Corp - Forward P/E Multiple|Projected Price to Earnings Ratio Embecta Corp.|TNDM: Forward P/E Multiple|Price to Future Earnings Ratio AXGN|SIBN (SI-BONE Medical) - Forward P/E Multiple|Orthofix International (OFIX) - Market Cap to Projected Earnings|Forward P/E Multiple BVS|Projected Price to Earnings OrthoPediatrics KIDS|Forward P/E Multiple TMCI (treace.com)|Forward P/E Multiple Blade Air Mobility SRTA|CARL - Future Price to Earnings|RXST: Future Price to Earnings|CLPT (ClearPoint) - Projected Price to Earnings|Stereotaxis, Inc. - Future Price to Earnings Multiple|STIM (Neuronetics, Inc) - Forward P/E Multiple|Projected Price to Earnings Ratio Sight Sciences Inc. SGHT|Future Price to Earnings orchestrabiomed.com (OBIO)|Anika (ANIK) - Forward Price to Earnings Multiple|InspireMD Inc. - Projected Price to Earnings|Forward P/E Multiple Jin Medical International Ltd ZJYL|Vivani Medical Inc - Forward P/E Multiple|Market Cap to Projected Earnings Xtant Medical XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Future Price to Earnings|Price to Expected Earnings Ratio MODD (Modular Med)|MYO (Myomo Inc.) - Forward P/E Multiple|Projected Price to Earnings Envoy Medical, Inc. (COCH)|Forward P/E Multiple VVOS|NVNO - Projected Price to Earnings Ratio|Future Price to Earnings sintx.com SINT|TNON: Price to Future Earnings Ratio|LFWD: Projected Price to Earnings|autonomix.com - Market Cap to Future Earnings Ratio|INVO Bioscience, Inc. (IVF) - Future Price to Earnings|BBLG (Bone Biologics Corp.) - Future Price to Earnings|Projected Price to Earnings AXNX|Biolase Inc. (BIOL) - Market Cap to Projected Earnings|Future Price to Earnings Dynatronics Corp. (DYNT)|Forward P/E Multiple Paragon 28 (FNA)|Future Price to Earnings INVO Bioscience INVO